超越性别的妇科:法国跨性别男性的宫颈癌筛查 (GYDECAT)
超越性别的妇科:通过对特定人群进行民意调查,探索和识别法国跨性别男性宫颈癌筛查的潜在障碍和杠杆
In France, cervical cancer screening is the subject of a national screening programme organized for all asymptomatic individuals aged 25 to 65 years with a cervix. The latter contributes greatly to the prevention and early treatment of this disease, whose public health challenge is recognized worldwide.
One of the objectives of this programme is to reduce inequalities in access. Transgender men, i.e. individuals assigned to the female gender at birth but identifying with the male gender, are concerned by this screening as long as they still have a cervix, according to the same modalities as for cisgender women.
However, they are often excluded from health care, including organized screening programs. Gender change in civil status is one of the obstacles.
The provision of gynaecological care is sometimes inadequate. The lack of knowledge of health professionals and the problems of discrimination that transgender people may face reduce the chances of having equitable access.
This survey aims to explore the perception that transgender men have of cervical cancer screening and to identify the challenges they face, the obstacles and the levers to access this prevention program.
研究概览
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Nîmes、法国、30900
- CHU de Nîmes
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Transgender men, i.e. individuals assigned the female gender at birth but identifying with the male gender, who retained the cervix
描述
Inclusion Criteria:
- transgender male (assigned female at birth but identifying as male)
- aged 25 to 65 years
- Having retained her cervix
- Having had sex before.
Exclusion Criteria:
- Under 25 and over 65
- Not having retained his cervix
- History of cancerous lesion of the cervix
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
prevalence of transgender men who have ever been screened for cervical cancer in their lifetime
大体时间:At study entry, basline (no follow-up)
|
answer yes to the question "Have you ever been screened for cervical cancer in your lifetime?" |
At study entry, basline (no follow-up)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
prevalence of transgender men who feel concerned about cervical cancer screening
大体时间:At study entry, basline (no follow-up)
|
answer yes to the question "Do you feel personally involved in cervical cancer screening?" |
At study entry, basline (no follow-up)
|
合作者和调查者
调查人员
- 首席研究员:ingrid JULIER、Centre Hospitalier Universitaire de Nīmes
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.